ATE306929T1 - Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden - Google Patents

Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden

Info

Publication number
ATE306929T1
ATE306929T1 AT99922293T AT99922293T ATE306929T1 AT E306929 T1 ATE306929 T1 AT E306929T1 AT 99922293 T AT99922293 T AT 99922293T AT 99922293 T AT99922293 T AT 99922293T AT E306929 T1 ATE306929 T1 AT E306929T1
Authority
AT
Austria
Prior art keywords
treatment
ribose
reperfusion injury
ischemic
inositol phosphoglycan
Prior art date
Application number
AT99922293T
Other languages
English (en)
Inventor
Thomas William Rademacher
Leslie Greenbaum
Patricia Mclean
Original Assignee
Sylus Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sylus Pharmaceuticals Ltd filed Critical Sylus Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE306929T1 publication Critical patent/ATE306929T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT99922293T 1998-06-29 1999-05-12 Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden ATE306929T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9814039.5A GB9814039D0 (en) 1998-06-29 1998-06-29 Materials and methods relating to the prevention or treatment of ischaemia-reperfusion injury
PCT/GB1999/001499 WO2000000205A1 (en) 1998-06-29 1999-05-12 Inositolphosphoglycan and ribose for treatment of ischaemia-reperfusion injury

Publications (1)

Publication Number Publication Date
ATE306929T1 true ATE306929T1 (de) 2005-11-15

Family

ID=10834599

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99922293T ATE306929T1 (de) 1998-06-29 1999-05-12 Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden

Country Status (9)

Country Link
US (1) US6900182B1 (de)
EP (1) EP1091743B1 (de)
JP (1) JP2002519328A (de)
AT (1) ATE306929T1 (de)
AU (1) AU748892B2 (de)
CA (1) CA2332969A1 (de)
DE (1) DE69927815T2 (de)
GB (1) GB9814039D0 (de)
WO (1) WO2000000205A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066765A2 (en) * 2000-03-07 2001-09-13 Millennium Pharmaceuticals, Inc. 26583, a serine/threonine phosphatase and uses thereof
US6953781B2 (en) * 2000-05-12 2005-10-11 Rodaris Pharmaceuticals Limited Compounds and their uses
JPWO2007129618A1 (ja) * 2006-05-08 2009-09-17 国立大学法人 香川大学 好中球の活性化および遊走因子の抑制剤およびその利用
WO2009123742A1 (en) * 2008-04-02 2009-10-08 St Cyr John A Use of ribose in first response to acute myocardial infarction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002258A1 (en) * 1986-10-06 1988-04-07 The University Of Virginia Alumni Patents Foundati Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
WO1997047192A1 (en) * 1996-06-14 1997-12-18 Biostore New Zealand Limited Compositions and methods for the preservation of living tissues
GB9618934D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in the treatment of diabetes and obesity
DE19649350A1 (de) * 1996-11-28 1998-06-04 Hoechst Ag Inositolglykane mit insulinartiger Wirkung

Also Published As

Publication number Publication date
US6900182B1 (en) 2005-05-31
EP1091743A1 (de) 2001-04-18
EP1091743B1 (de) 2005-10-19
DE69927815T2 (de) 2006-07-20
JP2002519328A (ja) 2002-07-02
AU3940299A (en) 2000-01-17
WO2000000205A1 (en) 2000-01-06
AU748892B2 (en) 2002-06-13
DE69927815D1 (de) 2006-03-02
GB9814039D0 (en) 1998-08-26
CA2332969A1 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
MY121548A (en) Compounds and methods for the treatment of cancer
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
DE69327544T2 (de) Mischungen zum schutz und regenierung von geweben
ATE279181T1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
PT735890E (pt) Misturas de 2',3'-didesoxi-inosina e hidroxicarbamida para inibicao da disseminacao retroviral
ES2126887T3 (es) Composiciones bronceadoras artificiales con estabilidad mejorada.
DK1112067T3 (da) Anvendelse af acetylcholinesteraseinhibitorer til fremstilling af farmaceutiske præparater til behandling af funktionelle og/eller organiske smertesyndromer
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
DK0920309T3 (da) Konjugeret linolensyre til bevaring eller forøgelse af mineralindhold i knogler
ATE282425T1 (de) Verfahren zur behandlung von endothelialen verletzungen
TR199701669A1 (xx) Deri preparasyonu i�in bile�imler.
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
BR9507730A (pt) Uso de formulações em gel como composições de tratamento
IS5856A (is) Aðferðir þar sem integrín-mótlyf eru notuð til aðmeðhöndla margföld mergæxli og uppsog í bein af völdum mergæxla
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
ATE222119T1 (de) Verwendung von erythropoietin zur behandlung von multiple myelom
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
ATE306929T1 (de) Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden
DE69927286D1 (de) Verwendung von humanen prostatazellinien zur behandlung von prostatakrebs
DE69922364D1 (de) Verfahren zur immunisierung und behandlung von h. pylori infektion
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
DE69429013D1 (de) Verwendung von dimeticon zur behandlung der konstipation
DE59811153D1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
DE69408664D1 (de) Zusammensetzungen zur behandlung von geernteter pflanzenmaterial

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties